HK1170745A1 - 的抗體 - Google Patents

的抗體

Info

Publication number
HK1170745A1
HK1170745A1 HK12111452.4A HK12111452A HK1170745A1 HK 1170745 A1 HK1170745 A1 HK 1170745A1 HK 12111452 A HK12111452 A HK 12111452A HK 1170745 A1 HK1170745 A1 HK 1170745A1
Authority
HK
Hong Kong
Prior art keywords
antibodies against
antibodies
Prior art date
Application number
HK12111452.4A
Other languages
English (en)
Inventor
安德努．尼爾．詹姆斯．麥肯錫
丹尼爾．內爾
Original Assignee
醫學研究委員會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 醫學研究委員會 filed Critical 醫學研究委員會
Publication of HK1170745A1 publication Critical patent/HK1170745A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK12111452.4A 2009-04-06 2012-11-13 的抗體 HK1170745A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16680809P 2009-04-06 2009-04-06
GBGB0905972.6A GB0905972D0 (en) 2009-04-06 2009-04-06 Antibodies against IL-17BR
PCT/GB2010/000639 WO2010116123A1 (en) 2009-04-06 2010-03-31 Antibodies against il-17br

Publications (1)

Publication Number Publication Date
HK1170745A1 true HK1170745A1 (zh) 2013-03-08

Family

ID=40750206

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111452.4A HK1170745A1 (zh) 2009-04-06 2012-11-13 的抗體

Country Status (11)

Country Link
US (2) US8586037B2 (zh)
EP (1) EP2417161B1 (zh)
JP (1) JP5767625B2 (zh)
CN (1) CN102482352B (zh)
AU (1) AU2010233535B2 (zh)
CA (1) CA2757104C (zh)
DK (1) DK2417161T3 (zh)
ES (1) ES2633767T3 (zh)
GB (1) GB0905972D0 (zh)
HK (1) HK1170745A1 (zh)
WO (1) WO2010116123A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130209485A1 (en) * 2011-10-31 2013-08-15 Riken Therapeutic agent of non-allergic airway inflammation and/or non-allergic hyperresponsive airway
WO2013186236A1 (en) * 2012-06-12 2013-12-19 Orega Biotech Antagonists of il-17 isoforms and their uses
EP3417878A1 (en) * 2012-06-12 2018-12-26 Orega Biotech Antagonists of il-17 isoforms and their uses
EP3160479A4 (en) * 2014-06-30 2018-07-04 Academia Sinica Antagonists for interleukin-17 receptor b (il-17rb) and its ligand il-17b for cancer therapy
US10372718B2 (en) * 2014-11-03 2019-08-06 SavantX, Inc. Systems and methods for enterprise data search and analysis
WO2016118568A1 (en) * 2015-01-20 2016-07-28 Lankenau Institute For Medical Research Methods and compositions for the treatment of diseases and disorders
GB201820006D0 (en) * 2018-12-07 2019-01-23 Lifearc Humanised anti-IL17BR antibody
EP3946377A1 (en) 2019-04-03 2022-02-09 Orega Biotech Combination therapies based on pd1 and il-17b inhibitors
WO2021170750A1 (en) 2020-02-28 2021-09-02 Orega Biotech Combination therapies based on ctla4 and il-17b inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5071972A (en) 1986-01-31 1991-12-10 Genetics Institute, Inc. DNA sequences encoding novel thrombolytic proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0276846A3 (en) 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
JP3720353B2 (ja) 1992-12-04 2005-11-24 メディカル リサーチ カウンシル 多価および多重特異性の結合タンパク質、それらの製造および使用
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
GB9809951D0 (en) 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules
PT1240325E (pt) * 1999-12-23 2010-01-07 Genentech Inc Polipéptidos homólogos de il-17 e il-17r e suas utilizações terapêuticas
AU2001236638A1 (en) 2000-02-04 2001-08-14 The Board Of Trustees Of The University Of Arkansas Evi27 gene sequences and protein encoded thereby
AR030554A1 (es) * 2000-03-16 2003-08-27 Amgen Inc Moleculas similares a receptores il-17 y usos de las mismas
GB0707505D0 (en) * 2007-04-18 2007-05-30 Medical Res Council Antibodies against il-25
RU2009140134A (ru) 2007-04-23 2011-05-27 Вайет (Us) Способы и композиции для лечения и мониторинга лечения связанных с ил-13 нарушений
JP5561689B2 (ja) 2007-11-28 2014-07-30 独立行政法人理化学研究所 Ｉｌ−１７ｒｂ陽性ｎｋｔ細胞を用いたアレルギー性気道炎症及び／又は気道過敏症の治療薬のスクリーニング方法
US20110052600A1 (en) * 2008-02-21 2011-03-03 Amgen Inc. Il-17ra-il-17rb antagonists and uses thereof
US9209965B2 (en) 2014-01-14 2015-12-08 Microsemi Semiconductor Ulc Network interface with clock recovery module on line card

Also Published As

Publication number Publication date
CN102482352B (zh) 2015-06-10
AU2010233535A1 (en) 2011-11-03
GB0905972D0 (en) 2009-05-20
US8852589B2 (en) 2014-10-07
US8586037B2 (en) 2013-11-19
JP2012522531A (ja) 2012-09-27
AU2010233535B2 (en) 2014-02-27
DK2417161T3 (en) 2017-07-31
EP2417161A1 (en) 2012-02-15
ES2633767T3 (es) 2017-09-25
US20140044718A1 (en) 2014-02-13
EP2417161B1 (en) 2017-05-24
CN102482352A (zh) 2012-05-30
WO2010116123A1 (en) 2010-10-14
JP5767625B2 (ja) 2015-08-19
US20120020985A1 (en) 2012-01-26
CA2757104C (en) 2018-07-24
CA2757104A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
IL214996A0 (en) Anti-bcma antibodies
GB0920127D0 (en) Antibodies
GB0909906D0 (en) Antibodies
ZA201104545B (en) Anti-siglec-15 antibody
EP2427496A4 (en) ANTI-VEGF-D ANTIBODIES
EP2241578A4 (en) ANTI-CLDN6 ANTIBODIES
ZA201102119B (en) Improved antibody libraies
EP2569012A4 (en) ANTI-FGFR2 ANTIBODY
GB201000467D0 (en) Antibodies
EP2481752A4 (en) MODIFIED CONSTANT ANTIBODY REGIONS
IL221371A0 (en) Anti-lrp6 antibodies
GB0821100D0 (en) Antibodies
IL217919A0 (en) Humanized anti-cdcp1 antibodies
EP2337798A4 (en) BSA-SPECIFIC ANTIBODIES
HK1194388A1 (zh) 抗缺刻蛋白 抗體
GB201020738D0 (en) Antibodies
GB0920324D0 (en) Antibodies
ZA201006099B (en) Anti-tyrp1 antibodies
GB201002238D0 (en) Antibodies
HK1170745A1 (zh) 的抗體
EP2426149A4 (en) ANTI-CADHERIN ANTIBODY
EP2629796A4 (en) ANTIBODY
ZA201007976B (en) Anti-pirb antibodies
GB0818356D0 (en) Antibodies
GB2473934B (en) Anti-VEEV antibody